ARCA biopharma Inc. (ABIO)

Business: ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases.

IPO Date: 08-Aug-1997

Co-Founder, Pres, CEO & Director: Dr. Michael R. Bristow M.D., Ph.D.

Chief Operating Officer: Mr. Thomas A. Keuer

Listing: NASDAQ: ABIO

Country: United States

Headquarters: Westminster, CO

Website: https://www.arcabio.com

Market cap: $34.87 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-16.68 Mln

Cash: $46.44 Mln

Total Debt: $0.33 Mln

Insider's Holding: 0.74%

Liquidity: Low

52 Week range: $1.71 - 3.17

Shares outstanding: 14,410,100

10 Years Aggregate:

• CFO: $-101.30 Mln
• EBITDA: $-109.76 Mln
• Net Profit: $-109.80 Mln